Salem Investment Counselors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-50
Closed -$2K 669
2019
Q4
$2K Hold
50
﹤0.01% 651
2019
Q3
$2K Hold
50
﹤0.01% 610
2019
Q2
$2K Buy
+50
New +$2.14K ﹤0.01% 633
2018
Q1
Sell
-50
Closed -$2K 516
2017
Q4
$2K Sell
50
-156
-76% -$7.17K ﹤0.01% 516
2017
Q3
$9K Sell
206
-1
-0.5% -$43 ﹤0.01% 460
2017
Q2
$8K Sell
207
-139
-40% -$5.25K ﹤0.01% 486
2017
Q1
$13K Hold
346
﹤0.01% 507
2016
Q4
$13K Sell
346
-9
-3% -$322 ﹤0.01% 475
2016
Q3
$123 Buy
+355
New +$12.4K ﹤0.01% 408

Other funds holding AVNS

Salem Investment Counselors's AVNS Position: Q1 2020 in Review

Salem Investment Counselors sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 50 shares — an estimated $2K sold.

Salem Investment Counselors first reported a position in AVNS in Q3 2016 and held it in 9 quarters. The position peaked at $13K in Q1 2017. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Salem Investment Counselors reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Salem Investment Counselors sold 50 Avanos Medical shares in Q1 2020, an estimated $2K.
  • Salem Investment Counselors first reported a position in Avanos Medical in Q3 2016 and held it in 9 quarters.
  • Salem Investment Counselors's Avanos Medical position peaked at $13K in Q1 2017.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Salem Investment Counselors's 13F filing for Q1 2020, filed 14 May 2020.